These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 14968215)
21. Alpha1-antitrypsin: PI type and lung tuberculosis. A negative report. Backman R; Riska H; Fröseth B; Hellström PE Eur J Respir Dis; 1983 Jan; 64(1):58-61. PubMed ID: 6600682 [TBL] [Abstract][Full Text] [Related]
22. [Prevalence of the alpha-1 antitrypsin phenotype in Hungary]. Szónyi L; Dobos M; Vásárhelyi B; Héninger E; Váczi Z Orv Hetil; 2003 Apr; 144(15):705-8. PubMed ID: 12774430 [TBL] [Abstract][Full Text] [Related]
23. [Edifice program: analysis of screening exam practices for cancer in France]. Blay JY; Eisinger F; Rixe O; Calazel-Benque A; Morère JF; Cals L; Coscas Y; Dolbeault S; Namer M; Serin D; Roussel C; Pivot X Bull Cancer; 2008 Nov; 95(11):1067-73. PubMed ID: 19036679 [TBL] [Abstract][Full Text] [Related]
24. Molecular epidemiology of lung and breast cancer. Ambrosone CB; Kato S; Bowman ED; Harrington AM; Blomeke B; Freudenheim JL; Graham S; Marshall JR; Vena JE; Brasure JR; Shields PG Eur J Cancer Prev; 1996 Oct; 5(5):391-2. PubMed ID: 8972270 [No Abstract] [Full Text] [Related]
25. Radiotherapy wait times for patients with a diagnosis of invasive cancer, 1992-2000. Johnston GM; MacGarvie VL; Elliott D; Dewar RA; MacIntyre MM; Nolan MC Clin Invest Med; 2004 Jun; 27(3):142-56. PubMed ID: 15305806 [TBL] [Abstract][Full Text] [Related]
26. [Relations between serum apha-antitrypsin level and neoplasms]. Apicella C; Carniato A; Ippoliti F; Romano V; Tomai A; Ferrari S Arch Sci Med (Torino); 1976; 133(2):103-8. PubMed ID: 1087553 [TBL] [Abstract][Full Text] [Related]
27. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis. Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862 [TBL] [Abstract][Full Text] [Related]
28. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study. Hippisley-Cox J; Vinogradova Y; Coupland C; Parker C Arch Gen Psychiatry; 2007 Dec; 64(12):1368-76. PubMed ID: 18056544 [TBL] [Abstract][Full Text] [Related]
29. Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer. Nanni S; Priolo C; Grasselli A; D'Eletto M; Merola R; Moretti F; Gallucci M; De Carli P; Sentinelli S; Cianciulli AM; Mottolese M; Carlini P; Arcelli D; Helmer-Citterich M; Gaetano C; Loda M; Pontecorvi A; Bacchetti S; Sacchi A; Farsetti A Mol Cancer Res; 2006 Feb; 4(2):79-92. PubMed ID: 16513839 [TBL] [Abstract][Full Text] [Related]
30. Trends in in-patient hospital utilization and surgical procedures for breast, prostate, lung and colorectal cancers in Canada. Neutel CI; Gao RN; Wai E; Gaudette LA Cancer Causes Control; 2005 Dec; 16(10):1261-70. PubMed ID: 16215877 [TBL] [Abstract][Full Text] [Related]
31. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Klabunde CN; Legler JM; Warren JL; Baldwin LM; Schrag D Ann Epidemiol; 2007 Aug; 17(8):584-90. PubMed ID: 17531502 [TBL] [Abstract][Full Text] [Related]
32. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients. Leeming DJ; Koizumi M; Byrjalsen I; Li B; Qvist P; Tankó LB Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):32-8. PubMed ID: 16434583 [TBL] [Abstract][Full Text] [Related]
33. Familial association of laryngeal, lung, stomach and early-onset breast cancer. Jaworowska E; Serrano-Fernández P; Tarnowska C; Lubiński J; Brzosko M; Flicinski J; Masojc B; Matyjasik J; Scott RJ; Narod SA; Lubiński J Breast Cancer Res Treat; 2008 Nov; 112(2):359-61. PubMed ID: 18097745 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers. Leu M; Reilly M; Czene K J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865 [TBL] [Abstract][Full Text] [Related]
35. Alpha 1-antitrypsin phenotypes in a Nigerian population. Olusi SO; Ladipo GO; Ojutiku OO Afr J Med Med Sci; 1982; 10(3-4):113-7. PubMed ID: 6289645 [TBL] [Abstract][Full Text] [Related]
36. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management. Glinsky GV J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963 [TBL] [Abstract][Full Text] [Related]
37. [Alpha 1-antitrypsin group system in lung cancer. II]. Ochmański W Folia Med Cracov; 1979; 21(2):333-41. PubMed ID: 317267 [No Abstract] [Full Text] [Related]
38. Alpha-antitrypsin genotypes in Korean patients with chronic obstructive pulmonary disease. Kim CH; Yim JJ; Yoo CG; Lee CT; Kim YW; Han SK; Shim YS Respirology; 2005 Mar; 10(2):223-8. PubMed ID: 15823189 [TBL] [Abstract][Full Text] [Related]
39. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. Govindarajan R; Ratnasinghe L; Simmons DL; Siegel ER; Midathada MV; Kim L; Kim PJ; Owens RJ; Lang NP J Clin Oncol; 2007 Apr; 25(12):1476-81. PubMed ID: 17442990 [TBL] [Abstract][Full Text] [Related]